RenovoRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.39	1.17	4.39	15.19	1.8	2.13
Short-Term Investments	0	0	2.05	0	0	0
Cash & Cash Equivalents	4.39	1.17	6.44	15.19	1.8	2.13
Cash Growth	17.89%	-81.79%	-57.61%	744.47%	-15.46%	-
Other Current Assets	0.4	0.29	0.83	1.09	0.11	0.14
Total Current Assets	4.79	1.47	7.27	16.28	1.91	2.27
Property, Plant & Equipment	0	0	0	0.01	0	0
Other Long-Term Assets	0	0	0	0	0	0
Total Long-Term Assets	0	0	0	0.01	0	0
Total Assets	4.79	1.47	7.27	16.29	1.91	2.27
Accounts Payable	0.36	0.56	0.53	0.53	0.16	0.54
Current Debt	0	0	0	0	2.77	0
Other Current Liabilities	0.74	0.61	0.57	0.41	1.17	0.27
Total Current Liabilities	1.09	1.18	1.1	0.94	4.1	0.81
Long-Term Debt	0	0	0	0	0.02	0
Other Long-Term Liabilities	1.93	3.29	0	0	0	0
Total Long-Term Liabilities	1.93	3.29	0	0	0.02	0
Total Liabilities	3.02	4.47	1.1	0.94	4.12	0.81
Total Debt	0	0	0	0	2.79	0
Retained Earnings	-42.48	-41.41	-31.17	-21.28	-14.96	-11.16
Comprehensive Income	0	0	0.02	0	0	0
Shareholders' Equity	1.77	-3	6.16	15.35	-14.66	-10.93
Net Cash / Debt	4.39	1.17	6.44	15.19	-0.99	2.13
Net Cash / Debt Growth	17.89%	-81.79%	-57.61%	-	-	-
Net Cash Per Share	0.29	0.11	0.71	2.91	-0.45	0.98
Working Capital	3.7	0.29	6.16	15.34	-2.19	1.46
Book Value Per Share	0.12	-0.29	0.68	2.94	-6.62	-5.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).